CRYO-CELL INTERNATIONAL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
CRYO-CELL INTERNATIONAL, INC. (CCEL) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $1.19 per share for the 6-month period ending 2026-05-31, per its 10-Q filed 2026-07-15.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-07-15
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2026-02-28 was $1.20, a 53.49% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2025-02-28 was $2.58, a 17.57% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2024-02-29 was $3.13, a 42.92% increase year-over-year.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2023-02-28 was $2.19.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2025 was $2.48, a 22.98% decline from fiscal 2024.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $3.22, a 40.61% increase from fiscal 2023.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $2.29, a 49.45% decline from fiscal 2022.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $4.53, a 25.37% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2026-05-31 | $1.19 10-Q · filed 2026-07-15 | |||
| 2026-02-28 | $1.20 10-Q · filed 2026-04-14 | |||
| 2025-11-30 | $2.48 10-K · filed 2026-02-27 | |||
| 2025-08-31 | $2.58 10-Q · filed 2025-10-15 | |||
| 2025-05-31 | $2.58 10-Q · filed 2026-07-15 | |||
| 2025-02-28 | $2.58 10-Q · filed 2025-04-14 | |||
| 2024-11-30 | $3.22 10-K · filed 2026-02-27 | |||
| 2024-08-31 | $3.13 10-Q · filed 2025-10-15 | |||
| 2024-05-31 | $3.13 10-Q · filed 2025-07-15 | |||
| 2024-02-29 | $3.13 10-Q · filed 2024-04-15 | |||
| 2023-11-30 | $2.29 10-K · filed 2025-02-28 | |||
| 2023-08-31 | $2.19 10-Q · filed 2024-10-15 | |||
| 2023-05-31 | $2.19 10-Q · filed 2024-07-15 | |||
| 2023-02-28 | $2.19 10-Q · filed 2023-04-21 | |||
| 2022-11-30 | $4.53 10-K · filed 2024-02-28 | |||
| 2022-08-31 | $4.56 10-Q · filed 2023-10-12 | |||
| 2022-05-31 | $4.56 10-Q · filed 2023-07-14 | |||
| 2021-11-30 | $6.07 10-K · filed 2023-02-28 | |||
| 2021-08-31 | $4.56 10-Q · filed 2022-10-18 | |||
| 2021-05-31 | $4.56 10-Q · filed 2022-07-11 | |||
| 2020-11-30 | $4.66 10-K · filed 2022-02-22 | |||
| 2020-08-31 | $4.94 10-Q · filed 2021-10-15 | |||
| 2020-05-31 | $5.03 10-Q · filed 2021-07-15 | |||
| 2020-02-29 | $5.03 10-Q · filed 2020-04-14 | |||
| 2019-11-30 | $5.02 10-K · filed 2021-03-01 | |||
| 2019-08-31 | $3.32 10-Q · filed 2020-10-15 | |||
| 2019-05-31 | $3.28 10-Q · filed 2019-07-15 | |||
| 2019-02-28 | $0.00 10-Q · filed 2019-04-15 | |||
| 2018-11-30 | $3.23 10-K · filed 2020-02-28 | |||
| 2018-08-31 | $3.23 10-Q · filed 2019-10-15 | |||
| 2018-05-31 | $3.23 10-Q · filed 2018-07-16 | |||
| 2018-02-28 | $0.00 10-Q · filed 2018-04-16 | |||
| 2017-11-30 | $3.23 10-K · filed 2019-02-28 | |||
| 2017-08-31 | $3.25 10-Q · filed 2018-10-15 | |||
| 2017-05-31 | $0.00 10-Q · filed 2017-07-07 | |||
| 2017-02-28 | $0.00 10-Q · filed 2017-04-13 | |||
| 2016-11-30 | $1.86 10-K · filed 2018-02-28 | |||
| 2016-08-31 | $1.86 10-Q · filed 2017-10-16 | |||
| 2016-05-31 | $1.91 10-Q · filed 2016-07-11 | |||
| 2016-02-29 | $0.00 10-Q · filed 2016-04-14 | |||
| 2015-11-30 | $1.90 10-K · filed 2016-02-29 | |||
| 2015-08-31 | $1.90 10-Q · filed 2015-10-15 | |||
| 2015-05-31 | $0.00 10-Q · filed 2015-07-15 | |||
| 2015-02-28 | $0.00 10-Q · filed 2015-04-14 | |||
| 2014-11-30 | $1.60 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |